Post-approval studies (Phase 4)Study completedNCT02580201
What this trial is testing
Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age
Who this might be right for
Poliomyelitis
Fidec Corporation 154
Showing 20 of 0 results